
- Pharmaceutical Technology-05-02-2021
- Volume 45
- Issue 5
Determining the Best Estimate of Probability of Passing Multiple Stage Tests: Part 1–Content Uniformity
This article introduces a practical approach to determining the best estimate for probability of passing uniformity of dosage units (content uniformity) using probability vs. lot coverage charts and tables constructed using simulated probability and lot coverage (LC1) data.
Peer-Reviewed
Submitted: August 24, 2020
Accepted: October 12, 2020
Abstract
This article introduces a practical approach to determining the best estimate for probability of passing uniformity of dosage units (content uniformity) using probability vs. lot coverage charts and tables constructed using simulated probability and lot coverage (LC1) data. The best estimation concept is to demonstrate that the probability estimates, especially for those approaching 100%, are slightly different (deviated) from the exact calculated values by not more than (NMT) the statistically acceptable deviation limits.
Peer-reviewed research
Submitted: Aug. 24, 2020
Accepted: Oct. 12, 2020
About the author
Pramote Cholayudth is an industrial pharmacist with more than 40 years of experiences. He is a guest speaker on Process Validation to industrial pharmaceutical scientists organized by Thailand’s FDA. He is the founder and manager of PM Consult and can be contacted via cpramote2000@yahoo.com.
Article details
Pharmaceutical Technology
Vol. 45, No. 5
May 2021
Pages: 36-43
Citation
When referring to this article, please cite it as P. Cholayudth, “Determining the Best Estimate of Probability of Passing Multiple Stage Tests: Part 1–Content Uniformity,” Pharmaceutical Technology 45 (5) 2021.
Articles in this issue
over 4 years ago
Injecting Innovation into Drug Packagingover 4 years ago
QbD Helps Evaluate Excipient Variabilityover 4 years ago
Overcoming Vaccine Development Challengesover 4 years ago
Beyond Lyophilizationover 4 years ago
Track-and-Trace Progress Benefits Supply-Chain Security Effortsover 4 years ago
Responding to FDA CAPA Requestsover 4 years ago
Evolving Analytical Technology Unravels Protein Characteristicsover 4 years ago
FDA and Industry Move to Renew New Drug User Fee Programsover 4 years ago
Moving Into the Next PhaseNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.





